Arrowstreet Capital, Limited Partnership Karuna Therapeutics, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

  • $121 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$123.79 - $277.42 $968,409 - $2.17 Million
7,823 Added 370.58%
9,934 $2.23 Million
Q2 2022

Aug 15, 2022
BUY
$93.97 - $143.33 $198,370 - $302,569
2,111 New
2,111 $267,000
Q1 2021

May 14, 2021
SELL
$95.46 - $133.08 $1.09 Million - $1.52 Million
-11,400 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$75.23 - $109.23 $857,622 - $1.25 Million
11,400 New
11,400 $1.16 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email